|  | Univariable analysis | Multivariable analysis (only preoperative factors) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p valuea | ||||||
Age | Continuous | 1.018 | 1.004–1.031 | 0.010 | 1.018 | 1.002–1.033 | 0.019 | ||||
Sex | Female | Ref | Â | Â | Ref | Â | Â | Â | Â | ||
 | Male | 0.844 | 0.642–1.109 | 0.220 | 1.049 | 0.785–1.402 | 0.745 | ||||
Location | RGS | Ref | Â | Â | Ref | Â | Â | Â | Â | ||
 | LGS | 1.34 | 1.055–1.702 | 0.018 | 1.371 | 1.073–1.752 | 0.012 | ||||
Resection type | Anatomical resection | Ref | Â | Â | Â | Â | Ref | Â | Â | Â | Â |
 | Non-anatomical resection | 1.407 | 1.119–1.768 | 0.003 | – | – | – | – | – | ||
ICGR | Continuous | 1.019 | 1.008–1.03 | 0.001 | 1.018 | 1.007–1.030 | 0.002 | ||||
AFP, ng/mL | < 13 | Ref | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | > 13.1 | 1.804 | 1.413–2.302 | < 0.001 | 1.777 | 1.384–2.282 | < 0.001 | ||||
PIVKA2, ng/mL | < 40 | Ref | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | > 41 | 1.597 | 1.267–2.012 | < 0.001 | 1.256 | 0.972–1.623 | 0.082 | ||||
Tumor size, cm | < 5 | Ref | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | > 5.1 | 2.134 | 1.647–2.766 | < 0.001 | 1.949 | 1.470–2.582 | < 0.001 | ||||
Operative time, min | < 270 | Ref |  | – |  |  |  |  |  |  |  |
 | > 271 | 1.708 | 1.350–2.162 | < 0.001 | – | – | – | – | – | ||
Blood loss, ml | < 300 | Ref |  | – |  |  |  |  |  |  |  |
 | > 301 | 1.590 | 1.216–2.079 | 0.001 | – | – | – | – | – | ||
HBV | Negative | Ref |  | – |  |  |  |  |  |  |  |
 | Positive | 0.697 | 0.487–0.998 | 0.049 | 0.943 | 0.635–1.400 | 0.771 | ||||
HCV | Negative | Ref |  | – |  |  |  |  |  |  |  |
 | Positive | 1.083 | 0.850–1.380 | 0.518 | – | – | – | – | – | ||
Hepatic vein invasion | Negative | Ref |  | – |  |  |  |  |  |  |  |
 | Positive | 2.180 | 1.350–3.518 | 0.001 | – | – | – | – | – | ||
Portal vein invasion | Negative | Ref |  | – |  |  |  |  |  |  |  |
 | Positive | 1.705 | 1.340–2.171 | < 0.001 | – | – | – | – | – |